Epitalon (Епіталон)

In mouse models — yes: Anisimov's 2006 study showed +25-50% lifespan extension. In humans there are no long-term randomized studies (50+ years) — therefore claims of "life extension" in humans are incorrect. However, there's clear evidence: telomerase activation, melatonin normalization, health marker improvement. Epitalon is one of the best-researched anti-aging peptides.

First Epitalon effects are noticeable from day 5–7 of the course: improved sleep (easier falling asleep, fewer night awakenings), circadian rhythm normalization. By end of 15–20 day course — improved skin hydration, tone, energy. Deep effects (telomerase, anti-aging) accumulate slowly — optimal assessment after 2–3 courses over a year. After one course, effects on circadian rhythm and skin last 4–6 months through epigenetic modulation. Objective markers (telomere length) can be measured after 6–12 months in specialized laboratories.

Yes, Epitalon synergizes excellently in anti-aging stack: with GHK-Cu (skin + cellular rejuvenation), with NAD+/NMN (mitochondrial energy + telomeres), with Sermorelin/CJC-1295 (GH-axis + anti-aging), with BPC-157 (regeneration). Don't combine: with high steroid doses or SARMs — conflict at cellular proliferation level.

Theoretical risk through telomerase activation — tumor cells often have hyperactive telomerase. Therefore Epitalon is STRICTLY contraindicated in active oncology or remission <5 years. In healthy individuals — long-term studies (Khavinson 2003-2020) showed NO increased oncological risks. Mandatory oncologist consultation with family cancer history.

Vladimir Khavinson is a Russian academician, director of Saint Petersburg Institute of Gerontology since 1992. Developer of peptide bioregulator concept (short synthetic peptides mimicking natural regulatory fragments). His school created: Epitalon (pineal), Prostamax (prostate), Thymalin (thymus), Retinalamin (retina). >40 years of research, hundreds of publications — largest scientific body on short peptides for anti-aging worldwide.

1 Epitalon pen 20mg (200 clicks × 100 μg) at standard 30–50 clicks/day dosage lasts 5–10 days. Therefore: full 15–20 day course = 2 pens; starter "short" 10 days = 1 pen (30 clicks/day); maintenance mini-course 5 days = 1/2 pen. Break between courses 15 days. Optimally 2–3 courses per year. DOZA consultant calculates exact pen quantity and protocol after assessing your goals and current condition.

Store refrigerated at 2–8°C temperature. Do not freeze — freezing destroys tetrapeptide structure. Protect from light. DOZA delivers pen in thermobox with 2–8°C cold chain — from warehouse to your door. Pen Peptide's stabilized MSSPT-formula tolerates brief temperature deviations above 8°C — minor delivery delays won't affect effectiveness.

Set pen programmer to 30, 40, or 50 clicks depending on prescribed dose. Subcutaneous injection into abdomen or front thigh, alternate sites. Short needle (4–6 mm), insert at 90°. After injection — wait 10 seconds before withdrawal. Preferably evening before bedtime — synchronizes action with natural melatonin peak. If evening injection disrupts sleep — shift to morning. Before first injection — detailed DOZA specialist consultation with technique demonstration.